Stifel Financial Corp Esperion Therapeutics, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.84 - $3.24 $220 - $388	-120 Reduced 0.41%	28,915 $64,000
Q1 2024 May 13, 2024	SELL	$2.02 - $3.02 $4,678 - $6,994	-2,316 Reduced 7.39%	29,035 $77,000
Q4 2023 Feb 12, 2024	SELL	$0.73 - $3.08 $12,393 - $52,289	-16,977 Reduced 35.13%	31,351 $93,000
Q3 2023 Nov 13, 2023	SELL	$0.96 - $1.79 $55,471 - $103,431	-57,783 Reduced 54.46%	48,328 $47,000
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $62,451 - $91,595	52,043 Added 96.25%	106,111 $147,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $41,626 - $208,130	28,511 Added 111.56%	54,068 $85,000
Q4 2022 Feb 13, 2023	SELL	$5.09 - $8.5 $22,009 - $36,754	-4,324 Reduced 14.47%	25,557 $159,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $38 - $56	-7 Reduced 0.02%	29,881 $200,000
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $98,419 - $137,622	-20,633 Reduced 40.84%	29,888 $190,000
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $102,491 - $170,614	30,686 Added 154.71%	50,521 $234,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $187 - $464	-39 Reduced 0.2%	19,835 $99,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $44,634 - $84,112	3,936 Added 24.7%	19,874 $239,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $28.71 $205,271 - $303,780	-10,581 Reduced 39.9%	15,938 $337,000
Q1 2021 May 14, 2021	BUY	$25.12 - $36.89 $32,103 - $47,145	1,278 Added 5.06%	26,519 $744,000
Q4 2020 Feb 12, 2021	SELL	$24.2 - $35.76 $278,130 - $410,989	-11,493 Reduced 31.29%	25,241 $657,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $28,342 - $47,913	-909 Reduced 2.41%	36,734 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $166,661 - $284,667	5,548 Added 17.29%	37,643 $1.93 Million
Q1 2020 May 14, 2020	SELL	$27.44 - $73.84 $96,122 - $258,661	-3,503 Reduced 9.84%	32,095 $1.01 Million
Q4 2019 Feb 13, 2020	BUY	$35.4 - $59.82 $244,649 - $413,416	6,911 Added 24.09%	35,598 $2.12 Million
Q3 2019 Nov 13, 2019	BUY	$34.47 - $47.53 $125,126 - $172,533	3,630 Added 14.49%	28,687 $1.05 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $123,909 - $161,699	3,090 Added 14.07%	25,057 $1.16 Million
Q1 2019 May 14, 2019	BUY	$40.11 - $53.57 $1,604 - $2,142	40 Added 0.18%	21,967 $878,000
Q4 2018 Feb 13, 2019	BUY	$36.99 - $59.11 $3,292 - $5,260	89 Added 0.41%	21,927 $1.02 Million
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $276,420 - $348,816	6,785 Added 45.07%	21,838 $966,000
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $94,554 - $199,556	2,612 Added 21.0%	15,053 $593,000
Q1 2018 May 11, 2018	BUY	$65.94 - $80.76 $117,505 - $143,914	1,782 Added 16.72%	12,441 $895,000
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $68,117 - $105,662	1,567 Added 17.23%	10,659 $702,000
Q3 2017 Nov 13, 2017	BUY	$43.8 - $52.77 $398,229 - $479,784	9,092	9,092 $0

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $171M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account